U.S. market Closed. Opens in 2 hours 50 minutes

BCTX | BriaCell Therapeutics Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue15.53K15.14K15.57K13.99K14.27KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross Profit-15.53K-15.14K-15.57K-13.99K-14.27KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Expenses23.27M-3.39K-3.69M-1.38M-946.42K-1.07M3.22M2.18M1.87M477.03K437.15K552.84K1.00M333.69K251.78K116.98K137.43K9.71K
Selling, General & Admin7.94M7.27M-3.67M-1.37M-932.17K-1.05M1.09M1.23M1.74M475.82K436.75K557.06K1.00M332.36K219.47KN/AN/AN/A
Research & Development15.34M8.02M1.32M2.22M3.74M2.39M2.13M944.94K137.67KN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A-15.29M-1.33M-2.24M-3.75M-312.92K290.001.79K565.001.21K404.00-4.23K2.40K1.33K32.31K116.98K137.43K9.71K
Operating Income-23.27M-15.29M3.69M1.38M946.42K-3.82M-2.58M-2.18M-1.87M-477.03K-437.15K-552.84K-1.00M-333.69K-251.78K-116.98K-137.43K-9.71K
Other Expenses / Income2.08M3.74M6.58M-72.25K343.74K-331.40K-638.59K-37.59K-1.61M-8.41M57.25K-444.68K-37.16K-595.34K2.51KN/AN/AN/A
Before Tax Income-20.30M-11.55M3.69M1.38M946.42K1.07M-3.22M-2.21M-3.49M-8.89M-379.90K-997.52KN/AN/AN/AN/AN/AN/A
Income Tax Expenses-152.62K30.73K6.58M-72.25K343.74K1.59MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-20.30M-11.58M-2.89M1.38M602.68K1.07M-3.22M-2.21M-3.49M-8.89M-379.90K-997.52K-1.03M-926.05K-246.33K-101.40K-123.96K-9.71K
Interest ExpensesN/A979.0046.09K27.00K23.82K15.63KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding15.62M15.49M4.52M713.89K579.66K427.81K339.67K288.44K247.51K59.00K59.00K58.83K32.67K18.17K8.93K4.84K4.17K2.05K
Diluted Shares Outstanding15.62M15.49M4.52M713.89K579.66K427.81K339.67K288.44K247.51K59.00K59.00K58.83K32.67K18.17K8.93K4.84K4.17K2.05K
EBITDA-22.37M-11.50M3.71M1.40M960.68K1.08M-3.21M-2.13M-249.27K7.95M-476.59K-68.35K-965.20K262.98K-251.61K-116.98K-137.43K-9.71K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-20.46M-11.55M3.74M1.34M970.24K2.67M-3.22M-2.21M-3.49M-8.89M-379.90K-997.52K-1.03M-926.05K-246.33K-101.40K-123.96K-9.71K
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-07-312022-07-312021-07-312020-07-312019-07-312018-07-312017-07-312016-07-312015-07-312014-07-312013-07-312012-07-312011-07-312010-07-312009-07-312008-07-312007-07-312006-07-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙